Methods and compositions for improving the immune response against viral pathogens
OwnerMichael Har-Noyinventor
Life of this patent
Estimating the term…
Abstract
Immunotherapy regimens against a viral pathogen in individuals are disclosed. The immunotherapy regimen is a universal vaccine that is administered intradermally. Multiple intradermal doses of the universal vaccine are administered to elderly individuals to prime the individual's immune system for an effective response against a viral pathogen.
Claims30
A method of improving the immune response in an individual against a viral pathogen comprising:
- administering allogeneic living immune cells where at least a portion are T-cells wherein the T-cells comprise effector/memory T-cells of a Th1 phenotype that produces IFN-γ and not IL-4.
A method of modulating the immune response in an individual at least 60 years of age comprising administering allogeneic living immune cells where at least a portion are T-cells wherein the T-cells comprise effector/memory T-cells of a Th1 phenotype that increases the Th1/Th2 ratio.
A method of increasing vaccine responsiveness in an individual fully vaccinated against at least one viral infection without additional doses of a vaccine for the at least one viral infection and comprising administering one or more doses of a vaccine composition to the fully vaccinated individual, the vaccine composition comprising allogeneic effector/memory Th-1 cells derived from a deliberately HLA-mismatched donor to the individual.
Dependencies are inferred from the claim text.